Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis

doi:10.5527/wjn.v10.i6.109

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4956)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

282

WORD

143

HTML

2133

Figures (1-4)

142

Tables (1-6)

151

Sum=2851

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

296

Download

883

Sum=1179

Publishing Process of This Article

Item

Count

Browse

295

Download

631

Sum=926

Nov 25, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Nephrol. Nov 25, 2021; 10(6): 109-121
Published online Nov 25, 2021. doi: 10.5527/wjn.v10.i6.109

Table 4 Comparisons of hemoglobin at each visit by infection status (n = 30)

Visit	Hemoglobin levels (g/dL), mean (SD)		P value
Visit	Infection (n = 11)	Non-infection (n = 19)	P value
Visit 2 (week 0; baseline)	6.41(1.48)	7.95 (0.75)	0.001^a	0.001^b
Visit 3 (week 2)	7.00 (1.51)	8.68 (1.33)	0.004^a
Visit 4 (week 4)	8.56 (1.53)	9.75 (1.33)	0.034^a
Visit 5 (week 8)	9.85 (1.40)	11.00 (1.36)	0.035^a
Visit 6 (week 12)	10.04 (1.73)	11.80 (1.39)	0.005^a

Data were presented as mean (standard deviation).

^aRepeated measure ANOVA comparing hemoglobin (Hb) level between patients with and without infection within each visit.

^bRepeated measure ANOVA testing the effect of infection on overall Hb level.

Citation: Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus^®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121
URL: https://www.wjgnet.com/2220-6124/full/v10/i6/109.htm
DOI: https://dx.doi.org/10.5527/wjn.v10.i6.109